The purpose of the investigation is to confirm the safety and efficacy in long-term use of Symbicort Turbuhaler in patients with Chronic obstructive pulmonary disease (COPD) under the post-marketing actual use.
Symbicort Turbuhaler 30/60 Special Clinical Experience Investigation for long-term use for COPD patients
Study Type
OBSERVATIONAL
Enrollment
1,183
Adverse event incidence
Time frame: 1 year
Clinical questionnaire about chronic obstructive pulmonary disease(CCQ)
Time frame: At baseline, Week 12, Week 26, 1 year
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.
Research Site
Aichi, Japan
Research Site
Akita, Japan
Research Site
Aomori, Japan
Research Site
Chiba, Japan
Research Site
Ehime, Japan
Research Site
Fukui, Japan
Research Site
Fukuoka, Japan
Research Site
Fukushima, Japan
Research Site
Gifu, Japan
Research Site
Gunma, Japan
...and 37 more locations